Epigenomics AG
Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of cancer. Its lead product is Epi proColon, a blood-based test for the early detection of colorectal cancer in the United States, Europe, and China. The co…
Medical - Diagnostics & Research
DE, Berlin [HQ]
Cash Flow Statements
15 Sheets · Starting from 2023In Million EUR. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||
| Operating Cash Flow (OCF) | -10.00 | -9.00 | -9.00 | -10.00 | -6.00 | -7.00 | -8.00 | -13.00 | -9.00 | -10.00 | -13.00 | -9.00 | -4.00 | -12.00 | -5.00 | |
| Operating Cash (Net) | -10.00 | -9.00 | -9.00 | -10.00 | -6.00 | -7.00 | -8.00 | -13.00 | -9.00 | -10.00 | -13.00 | -9.00 | -4.00 | -12.00 | -5.00 | |
| Accounts Receivable | - - | - - | - - | - - | - - | - - | - - | -2.00 | 1.00 | - - | - - | - - | - - | - - | - - | |
| Accounts Payable | - - | - - | - - | - - | - - | - - | - - | -1.00 | - - | - - | - - | - - | -1.00 | - - | - - | |
|
Working Capital
|
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Change | -1.00 | - - | 1.00 | - - | - - | - - | - - | -1.00 | - - | 1.00 | - - | - - | - - | - - | - - | |
| Other WC | -1.00 | - - | 1.00 | - - | - - | - - | - - | -2.00 | - - | 1.00 | - - | - - | - - | - - | - - | |
| Investing Activities | ||||||||||||||||
| Used Cash (Net) | - - | - - | -2.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | -1.00 | - - | |
| Capital Expenditure | - - | - - | -3.00 | - - | - - | - - | - - | -1.00 | - - | - - | - - | - - | - - | -1.00 | - - | |
| Purchases of Investments | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Sale/Maturity of Investment | - - | - - | - - | 1.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Property, Plant, Equipment (P&PE) | - - | - - | -3.00 | - - | - - | - - | - - | -1.00 | - - | - - | - - | - - | - - | -1.00 | - - | |
| Acquisitions (Net) | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Investing Activities | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Financing Activities | ||||||||||||||||
| Used Cash (Net) | -4.00 | -30.00 | - - | - - | -11.00 | -7.00 | -9.00 | -17.00 | -11.00 | -13.00 | -7.00 | -2.00 | -21.00 | - - | - - | |
| Debt Repayment | - - | - - | - - | - - | - - | - - | -4.00 | -4.00 | - - | -6.00 | - - | - - | -19.00 | - - | - - | |
| Dividends Paid | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Common Stock
|
5 | 35 | - - | - - | 9 | - - | 5 | 14 | 5 | 23 | 9 | 4 | 2 | - - | - - | |
| Issued | 5.00 | 33.00 | - - | - - | 9.00 | 4.00 | 5.00 | 13.00 | 5.00 | 21.00 | 8.00 | 3.00 | 2.00 | - - | - - | |
| Repurchased | - - | -2.00 | - - | - - | - - | - - | - - | - - | - - | -1.00 | - - | - - | - - | - - | - - | |
| Other Financing Activities | - - | - - | - - | - - | 3.00 | 3.00 | 4.00 | 4.00 | 6.00 | 13.00 | - - | - - | 59.00 | - - | - - | |
| Cash Balances | ||||||||||||||||
| Begin of Period | 9.00 | 3.00 | 24.00 | 12.00 | 2.00 | 7.00 | 6.00 | 7.00 | 11.00 | 12.00 | 16.00 | 10.00 | 3.00 | 23.00 | 7.00 | |
| End of Period | 3.00 | 24.00 | 12.00 | 2.00 | 7.00 | 6.00 | 7.00 | 11.00 | 12.00 | 16.00 | 10.00 | 3.00 | 23.00 | 10.00 | 2.00 | |
| Change | -5.00 | 20.00 | -11.00 | -10.00 | 5.00 | - - | 1.00 | 3.00 | 1.00 | 3.00 | -6.00 | -6.00 | 19.00 | -12.00 | -5.00 | |
| Non-Cash Balances | ||||||||||||||||
| Depreciation and Amortization | - - | 1.00 | 4.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Stock Based Compensation | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other | - - | - - | - - | - - | - - | - - | - - | -1.00 | - - | - - | - - | - - | - - | - - | -1.00 | |
| Highlighted metrics | ||||||||||||||||
| Free Cash Flow (FCF) | -10.00 | -10.00 | -12.00 | -10.00 | -6.00 | -8.00 | -8.00 | -14.00 | -10.00 | -10.00 | -13.00 | -9.00 | -4.00 | -13.00 | -5.00 | |
| Cash Conversion Cycle (CCC) | -81.00 | -651.00 | -912.00 | -1,715.00 | -418.00 | 83.00 | -70.00 | 38.00 | -589.00 | -694.00 | -1,396.00 | -903.00 | -846.00 | -10,071.00 | -1,341.00 | |
| Invested Capital | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Other Operating Inflows/Outflows
|
||||||||||||||||
| Forex Effect on Cash | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | 1.00 | 1.00 | - - |